
Read More
Pharma Company Share Price Surges Over 2.5% After U.S. FDA Inspection Updat...
The stock has gained 66.36 per cent from its 52-week low of Rs 1,016.10 per share....

The stock has gained 66.36 per cent from its 52-week low of Rs 1,016.10 per share....

Maruti Suzuki's price hike, Aurobindo Pharma's regulatory approval in Brazil and JSW Infrastructure'...

RVNL bags large infrastructure orders, Aurobindo Pharma expands in France, while Dilip Buildcon secu...

India’s stock market recovered strongly on April 6 amid U.S.-Iran ceasefire hopes, with key focus on...

Aurobindo Pharma approves Rs 800 crore buyback at Rs 1,475 per share, representing 0.93 per cent of ...

The company has a market cap of over Rs 70,000 crore and the stock is up by 24.3 per cent from its 5...

The company has a market cap of over Rs 70,000 crore and the stock is up by 23 per cent from its 52-...

The biosimilars division alongside niche product development represents Aurobindo Pharma's main focu...